AVXL · Anavex Life Sciences Corp.
Market Cap
$265.11M
Shares
92.70M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-02 | — | |
| 10-Q | 2026-08-28 | 2026-06-30 | |
| 10-Q/A | 2026-08-28 | 2025-12-31 | |
| 10-K/A | 2026-08-28 | 2025-09-30 | |
| 10-Q | 2026-08-28 | 2026-03-31 | |
| 8-K | 2026-08-25 | — | |
| 8-K | 2026-08-17 | — | |
| 8-K | 2026-08-11 | — | |
| 8-K | 2026-08-03 | — | |
| 8-K | 2026-07-30 | — | |
| 8-K | 2026-07-20 | — | |
| 8-K | 2026-06-26 | 2026-06-25 | |
| 8-K | 2026-05-22 | 2026-05-20 | |
| 8-K | 2026-05-15 | 2026-05-11 | |
| 8-K | 2026-05-06 | 2026-04-30 | |
| 8-K | 2026-03-25 | — | |
| 8-K | 2026-02-25 | 2026-02-20 | |
| 10-Q | 2026-02-09 | 2025-12-31 | |
| 8-K | 2026-02-09 | — | |
| 8-K | 2025-11-25 | — | |
| 10-K | 2025-11-25 | 2025-09-30 | |
| 8-K | 2025-11-14 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-07-28 | 2025-07-25 | |
| 8-K | 2025-07-03 | — | |
| 8-K | 2025-06-13 | 2025-06-10 | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| DEF 14A | 2025-04-25 | — | |
| 10-Q | 2025-02-12 | 2024-12-31 | |
| 10-K | 2024-12-23 | 2024-09-30 | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-07-30 | 2024-07-24 | |
| 8-K | 2024-06-21 | 2024-06-18 | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-05-06 | — | |
| 10-Q | 2024-02-07 | 2023-12-31 | |
| 10-K | 2023-11-27 | 2023-09-30 | |
| 10-Q | 2023-08-08 | 2023-06-30 | |
| 8-K | 2023-05-24 | 2023-05-23 | |
| 10-Q | 2023-05-09 | 2023-03-31 | |
| 8-K | 2023-04-14 | 2023-04-11 | |
| DEF 14A | 2023-04-04 | — | |
| 8-K | 2023-03-13 | 2023-03-10 | |
| 10-Q | 2023-02-07 | 2022-12-31 | |
| 8-K | 2023-02-07 | — | |
| 10-K/A | 2023-01-27 | 2022-09-30 | |
| 8-K | 2022-12-02 | 2022-12-01 | |
| 10-K | 2022-11-28 | 2022-09-30 | |
| 10-Q | 2022-08-09 | 2022-06-30 |
Showing 1–50 of 79 filings